Fig. 35From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseInteraction of compound C40 docked into the binding site of AChE. The hydrophobic bromo substituent of C40 is oriented toward a hydrophilic pocket of active site [50]Back to article page